Weiner, January
Lewis, David J. M.
Maertzdorf, Jeroen
Mollenkopf, Hans-Joachim http://orcid.org/0000-0003-1167-4783
Bodinham, Caroline
Pizzoferro, Kat
Linley, Catherine http://orcid.org/0000-0002-7649-8146
Greenwood, Aldona
Mantovani, Alberto
Bottazzi, Barbara
Denoel, Philippe
Leroux-Roels, Geert
Kester, Kent E. http://orcid.org/0000-0002-5056-0802
Jonsdottir, Ingileif http://orcid.org/0000-0001-8339-150X
van den Berg, Robert http://orcid.org/0000-0003-2708-7890
Kaufmann, Stefan H. E. http://orcid.org/0000-0001-9866-8268
Del Giudice, Giuseppe
Funding for this research was provided by:
Innovative Medicines Initiative (115308)
Article History
Received: 2 August 2019
Accepted: 10 December 2019
First Online: 30 December 2019
Competing interests
: P.D., R.v.d.B. and G.D.G. are employees of the GSK group of companies, and report receiving restricted shares of the company. K.K. is employee of Sanofi Pasteur. I.J. is employee of deCode genetics/Amgen Inc. A.M. and B.B. are receiving royalties for reagents to measure PTX3 levels. Other authors report no conflict of interest.